Atomoxetine HCL 80 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FWGA8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,342
Award facts
- Contract value 100% obligated
- $1,341.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Atomoxetine HCL 80 mg capsules in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,341.60 and an ultimate completion date of September 24, 2025. The award was made on a competitive basis with no set-aside designation, and performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. Atomoxetine is a selective norepinephrine reuptake inhibitor commonly used in the treatment of attention-deficit/hyperactivity disorder (ADHD), making this pharmaceutical supply essential to military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements through multiple contract awards with the Defense Logistics Agency across diverse therapeutic domains including specialty medications, vaccines, and medical supplies for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FWGA8?
SPE2DB25FWGA8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FWGA8 worth?
The government has obligated $1,342 on SPE2DB25FWGA8.
Is contract SPE2DB25FWGA8 an order under another contract?
Yes. SPE2DB25FWGA8 is a delivery order under SPE2DB24D1034, an indefinite delivery contract.
Was contract SPE2DB25FWGA8 competed?
The extent of competition for SPE2DB25FWGA8 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award